Systems biology approaches to understanding epithelial mesenchymal transition (EMT) in mucosal remodeling and signaling in asthma

World Allergy Organization Journal

Volumn 7, Issue 1, 2014, Pages

  Ijaz, Talha ^a   Pazdrak, Konrad ^a,b   Kalita, Mridul ^a,b   Konig, Rolf ^a,b   Choudhary, Sanjeev ^a,b   Tian, Bing ^a   Boldogh, Istvan ^a,b   Brasier, Allan R ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

EMT; Eosinophils; Inflammation; Innate immunity; NF B; Systems biology; TGF

Indexed keywords

ADAPTIVE IMMUNITY; AIRWAY REMODELING; ASTHMA; CELL TRANSDIFFERENTIATION; EFFECTOR CELL; EPITHELIAL MESENCHYMAL TRANSITION; HIGH THROUGHPUT SEQUENCING; HUMAN; INNATE IMMUNITY; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TRANSLATIONAL RESEARCH;

EID: 84910643436     PISSN: None     EISSN: 19394551     Source Type: Journal    
DOI: 10.1186/1939-4551-7-13     Document Type: Review

References (117)

1. Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. LJ Akinbami, JE Moorman, C Bailey, HS Zahran, M King, CA Johnson, X Liu, NCHS Data Brief 2012 94 1 8 22617340
2. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. GP Anderson, Lancet 2008 372 1107 1119 10.1016/S0140-6736(08)61452-X 18805339
3. Asthma. WW Busse, RF Lemanske Jr, N Engl J Med 2001 344 350 362 10.1056/NEJM200102013440507 11172168
4. Characterization of the severe asthma phenotype by the national heart, lung, and blood institute's severe asthma research program. WC Moore, ER Bleecker, D Curran-Everett, SC Erzurum, BT Ameredes, L Bacharier, WJ Calhoun, M Castro, KF Chung, MP Clark, RA Dweik, AM Fitzpatrick, B Gaston, M Hew, I Hussain, NN Jarjour, E Israel, BD Levy, JR Murphy, SP Peters, WG Teague, DA Meyers, WW Busse, SE Wenzel, J Allergy Clin Immunol 2007 119 405 413 10.1016/j.jaci.2006.11.639 17291857
5. An integrative systems biology approach to understanding pulmonary diseases. C Auffray, IM Adcock, KF Chung, R Djukanovic, C Pison, PJ Sterk, Chest 2010 137 1410 1416 10.1378/chest.09-1850 20525651
6. Gene-environment interactions in asthma and allergic diseases: challenges and perspectives. F Kauffmann, F Demenais, J Allergy Clin Immunol 2012 130 1229 1240 quiz 1241-1222 10.1016/j.jaci.2012.10.038 23195523
7. An environmental systems biology approach to the study of asthma. W Toscano, K Oehlke, R Kafoury, Allergy Frontiers: Future Perspectives Japan: Springer, Pawankar R, Holgate S, Rosenwasser L, 6 2010 239 252 Allergy Frontiers
8. The airway epithelium: structural and functional properties in health and disease. D Knight, ST Holgate, Respirology 2010 8 432 446
9. The airway epithelium in asthma. BN Lambrecht, H Hammad, Nat Med 2012 18 684 692 10.1038/nm.2737 22561832
10. Identification of innate immune response endotypes in asthma: implications for personalized medicine. AR Brasier, Curr Allergy Asthma Rep 2013 13 462 468 10.1007/s11882-013-0363-y 23793609
11. Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. SL Constant, JL Brogdon, DA Piggott, CA Herrick, I Visintin, NH Ruddle, K Bottomly, J Clin Invest 2002 110 1441 1448 10.1172/JCI0216109 12438442
12. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. KK Kim, MC Kugler, PJ Wolters, L Robillard, MG Galvez, AN Brumwell, D Sheppard, HA Chapman, Proc Natl Acad Sci U S A 2006 103 13180 13185 10.1073/pnas.0605669103 16924102
13. Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. ST Holgate, J Holloway, S Wilson, F Bucchieri, S Puddicombe, DE Davies, Proc Am Thorac Soc 2004 1 93 98 10.1513/pats.2306034 16113419
14. Epithelial-mesenchymal interactions in the pathogenesis of asthma. ST Holgate, DE Davies, PM Lackie, SJ Wilson, SM Puddicombe, JL Lordan, J Allergy Clin Immunol 2000 105 193 204 10.1016/S0091-6749(00)90066-6 10669837
15. The basics of epithelial-mesenchymal transition. R Kalluri, RA Weinberg, J Clin Invest 2009 119 1420 1428 10.1172/JCI39104 19487818
16. Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1. G Zhou, LA Dada, M Wu, A Kelly, H Trejo, Q Zhou, J Varga, JI Sznajder, Am J Physiol Lung Cell Mol Physiol 2009 297 1120 L1130 10.1152/ajplung.00007.2009 19801454
17. Transdifferentiation of cultured tubular cells induced by hypoxia. K Manotham, T Tanaka, M Matsumoto, T Ohse, R Inagi, T Miyata, K Kurokawa, T Fujita, JR Ingelfinger, M Nangaku, Kidney Int 2004 65 871 880 10.1111/j.1523-1755.2004.00461.x 14871406
18. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. DY Rhyu, Y Yang, H Ha, GT Lee, JS Song, ST Uh, HB Lee, J Am Soc Nephrol 2005 16 667 675 10.1681/ASN.2004050425 15677311
19. TGF-beta and epithelial-to-mesenchymal transitions. J Zavadil, EP Böttinger, Oncogene 2005 24 5764 5774 10.1038/sj.onc.1208927 16123809
20. Systems approaches to modeling chronic mucosal inflammation. M Kalita, B Tian, B Gao, S Choudhary, TG Wood, JR Carmical, I Boldogh, S Mitra, JD Minna, AR Brasier, BioMed Res Int 2013 in press
21. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. M Zeisberg, C Yang, M Martino, MB Duncan, F Rieder, H Tanjore, R Kalluri, J Biol Chem 2007 282 23337 23347 10.1074/jbc.M700194200 17562716
22. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. M Zeisberg, J Hanai, H Sugimoto, T Mammoto, D Charytan, F Strutz, R Kalluri, Nat Med 2003 9 964 968 10.1038/nm888 12808448
23. Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. WI de Boer, HS Sharma, SMI Baelemans, HC Hoogsteden, BN Lambrecht, GJ Braunstahl, Can J Physiol Pharmacol 2008 86 105 112 10.1139/Y08-004 18418437
24. Activation of TGF-beta/Smad2 signaling is associated with airway remodeling in asthma. H Sagara, T Okada, K Okumura, H Ogawa, C Ra, T Fukuda, A Nakao, J Allergy Clin Immunol 2002 110 249 254 10.1067/mai.2002.126078 12170265
25. Expression of transforming growth factor beta1 in bronchial biopsies in asthma and COPD. N Kokturk, T Tatlicioglu, L Memis, N Akyurek, G Akyol, J Asthma 2003 40 887 893 10.1081/JAS-120023580 14736088
26. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. AM Vignola, P Chanez, G Chiappara, A Merendino, E Pace, A Rizzo, AM la Rocca, V Bellia, G Bonsignore, J Bousquet, Am J Respir Crit Care Med 1997 156 591 599 10.1164/ajrccm.156.2.9609066 9279245
27. A new look at the pathogenesis of asthma. ST Holgate, HS Arshad, GC Roberts, PH Howarth, P Thurner, DE Davies, Clin Sci 2010 118 439 450
28. Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. TL Hackett, SM Warner, D Stefanowicz, F Shaheen, DV Pechkovsky, LA Murray, R Argentieri, A Kicic, SM Stick, TR Bai, DA Knight, Am J Respir Crit Care Med 2009 180 122 133 10.1164/rccm.200811-1730OC 19406982
29. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. CG Lee, SJ Cho, MJ Kang, SP Chapoval, PJ Lee, PW Noble, T Yehualaeshet, B Lu, RA Flavell, J Milbrandt, RJ Homer, JA Elias, J Exp Med 2004 200 377 389 10.1084/jem.20040104 15289506
30. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. SJ McMillan, G Xanthou, CM Lloyd, J Immunol 2005 174 5774 5780 10.4049/jimmunol.174.9.5774 15843580
31. Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease. JF Alcorn, LM Rinaldi, EF Jaffe, M van Loon, JH Bates, YM Janssen-Heininger, CG Irvin, Am J Respir Crit Care Med 2007 176 974 982 10.1164/rccm.200702-334OC 17761617
32. Sputum levels of transforming growth factor-beta1 in asthma: relation to clinical and computed tomography findings. M Yamaguchi, A Niimi, H Matsumoto, T Ueda, M Takemura, H Matsuoka, M Jinnai, K Otsuka, T Oguma, T Takeda, I Ito, K Chin, M Mishima, J Investig Allergol Clin Immunol 2008 18 202 206 18564632
33. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. C Boxall, ST Holgate, DE Davies, Eur Respir J 2006 27 208 229 10.1183/09031936.06.00130004 16387953
34. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. BC Willis, Z Borok, Am J Physiol Lung Cell Mol Physiol 2007 293 525 L534 10.1152/ajplung.00163.2007 17631612
35. Transforming growth factor beta 1 increases fibronectin deposition through integrin receptor alpha 5 beta 1 on human airway smooth muscle. LM Moir, JK Burgess, JL Black, J Allergy Clin Immunol 2008 121 1034 1039 e1034 10.1016/j.jaci.2007.12.1159 18243286
36. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. BA Hocevar, TL Brown, PH Howe, EMBO J 1999 18 1345 1356 10.1093/emboj/18.5.1345 10064600
37. ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition. JM Buonato, MJ Lazzara, Cancer Res 2014 74 309 319 10.1158/0008-5472.CAN-12-4721 24108744
38. Inhibition of epithelial-to-mesenchymal transition and pulmonary fibrosis by methacycline. Y Xi, K Tan, AN Brumwell, SC Chen, YH Kim, TJ Kim, Y Wei, HA Chapman, Am J Respir Cell Mol Biol 2014 50 51 60 23944988
39. Interactions between beta-catenin and transforming growth factor-beta signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). B Zhou, Y Liu, M Kahn, DK Ann, A Han, H Wang, C Nguyen, P Flodby, Q Zhong, MS Krishnaveni, JM Liebler, P Minoo, ED Crandall, Z Borok, J Biol Chem 2012 287 7026 7038 10.1074/jbc.M111.276311 22241478
40. TGF-beta signaling and epithelial-mesenchymal transition in cancer progression. Y Katsuno, S Lamouille, R Derynck, Curr Opin Oncol 2013 25 76 84 10.1097/CCO.0b013e32835b6371 23197193
41. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. T Vincent, EP Neve, JR Johnson, A Kukalev, F Rojo, J Albanell, K Pietras, I Virtanen, L Philipson, PL Leopold, RG Crystal, AG de Herreros, A Moustakas, RF Pettersson, J Fuxe, Nat Cell Biol 2009 11 943 950 10.1038/ncb1905 19597490
42. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. CP Bracken, PA Gregory, N Kolesnikoff, AG Bert, J Wang, MF Shannon, GJ Goodall, Cancer Res 2008 68 7846 7854 10.1158/0008-5472.CAN-08-1942 18829540
43. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). H Kasai, JT Allen, RM Mason, T Kamimura, Z Zhang, Respir Res 2005 6 56 10.1186/1465-9921-6-56 15946381
44. Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. J Camara, G Jarai, Fibrogenesis Tissue Repair 2010 3 2 10.1186/1755-1536-3-2 20051102
45. TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids. AM Doerner, BL Zuraw, Respir Res 2009 10 100 10.1186/1465-9921-10-100 19857272
46. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. [Review] [53 refs]. PJ Barnes, M Karin, N Engl J Med 1997 336 1066 1071 10.1056/NEJM199704103361506 9091804
47. A probabilistic approach to learn chromatin architecture and accurate inference of the NF-kappaB/RelA regulatory network using ChIP-Seq. J Yang, A Mitra, N Dojer, S Fu, M Rowicka, AR Brasier, Nucleic Acids Res 2013 41 7240 7259 10.1093/nar/gkt493 23771139
48. Identification of direct genomic targets downstream of the nuclear factor-{kappa}B transcription factor mediating tumor necrosis factor signaling. B Tian, DE Nowak, M Jamaluddin, S Wang, AR Brasier, J Biol Chem 2005 280 17435 17448 10.1074/jbc.M500437200 15722553
49. Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail. HJ Kim, BC Litzenburger, X Cui, DA Delgado, BC Grabiner, X Lin, MT Lewis, MM Gottardis, TW Wong, RM Attar, JM Carboni, AV Lee, Mol Cell Biol 2007 27 3165 3175 10.1128/MCB.01315-06 17296734
50. Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1. CW Li, W Xia, L Huo, SO Lim, Y Wu, JL Hsu, CH Chao, H Yamaguchi, NK Yang, Q Ding, Y Wang, YJ Lai, AM LaBaff, TJ Wu, BR Lin, MH Yang, GN Hortobagyi, MC Hung, Cancer Res 2012 72 1290 1300 10.1158/0008-5472.CAN-11-3123 22253230
51. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Y Wu, J Deng, PG Rychahou, S Qiu, BM Evers, BP Zhou, Cancer Cell 2009 15 416 428 10.1016/j.ccr.2009.03.016 19411070
52. The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling. TA Doherty, P Soroosh, N Khorram, S Fukuyama, P Rosenthal, JY Cho, PS Norris, H Choi, S Scheu, K Pfeffer, BL Zuraw, CF Ware, DH Broide, M Croft, Nat Med 2011 17 596 603 10.1038/nm.2356 21499267
53. Tumor necrosis factor superfamily member LIGHT induces epithelial-mesenchymal transition in A549 human alveolar epithelial cells. Y Mikami, Y Yamauchi, M Horie, M Kase, T Jo, H Takizawa, T Kohyama, T Nagase, Biochem Biophys Res Commun 2012 428 451 457 10.1016/j.bbrc.2012.10.097 23131560
54. Notch induces myofibroblast differentiation of alveolar epithelial cells via transforming growth factor-{beta}-Smad3 pathway. K Aoyagi-Ikeda, T Maeno, H Matsui, M Ueno, K Hara, Y Aoki, F Aoki, T Shimizu, H Doi, K Kawai-Kowase, T Iso, T Suga, M Arai, M Kurabayashi, Am J Respir Cell Mol Biol 2011 45 136 144 21749980
55. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. PC Fulkerson, CA Fischetti, ML McBride, LM Hassman, SP Hogan, ME Rothenberg, Proc Natl Acad Sci U S A 2006 103 16418 16423 10.1073/pnas.0607863103 17060636
56. A critical role for eosinophils in allergic airways remodeling. AA Humbles, CM Lloyd, SJ McMillan, DS Friend, G Xanthou, EE McKenna, S Ghiran, NP Gerard, C Yu, SH Orkin, C Gerard, Science 2004 305 1776 1779 10.1126/science.1100283 15375268
57. Inhibition of airway remodeling in IL-5-deficient mice. JY Cho, M Miller, KJ Baek, JW Han, J Nayar, SY Lee, K McElwain, S McElwain, S Friedman, DH Broide, J Clin Invest 2004 113 551 560 10.1172/JCI19133 14966564
58. Role of transforming growth factor-beta in airway remodeling in asthma. R Halwani, S Al-Muhsen, H Al-Jahdali, Q Hamid, Am J Respir Cell Mol Biol 2011 44 127 133 10.1165/rcmb.2010-0027TR 20525803
59. A crucial role for host APCs in the induction of donor CD4 + CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. I Tawara, WD Shlomchik, A Jones, W Zou, E Nieves, C Liu, T Toubai, R Duran-Struuck, Y Sun, SG Clouthier, R Evers, KP Lowler, RB Levy, P Reddy, J Immunol 2010 185 3866 3872 10.4049/jimmunol.1001625 20810991
60. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. TR Cox, JT Erler, Dis Model Mech 2011 4 165 178 10.1242/dmm.004077 21324931
61. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. KK Kim, Y Wei, C Szekeres, MC Kugler, PJ Wolters, ML Hill, JA Frank, AN Brumwell, SE Wheeler, JA Kreidberg, HA Chapman, J Clin Invest 2009 119 213 224 19104148
62. House dust mite-promoted epithelial-to-mesenchymal transition in human bronchial epithelium. IH Heijink, DS Postma, JA Noordhoek, M Broekema, A Kapus, Am J Respir Cell Mol Biol 2010 42 69 79 10.1165/rcmb.2008-0449OC 19372245
63. Respiratory syncytial virus potentiates ABCA3 mutation-induced loss of lung epithelial cell differentiation. E Kaltenborn, S Kern, S Frixel, L Fragnet, KK Conzelmann, R Zarbock, M Griese, Hum Mol Genet 2012 21 2793 2806 10.1093/hmg/dds107 22434821
64. Asthma. From bronchoconstriction to airways inflammation and remodeling. J Bousquet, PK Jeffery, WW Busse, M Johnson, AM Vignola, Am J Respir Crit Care Med 2000 161 1720 1745 10.1164/ajrccm.161.5.9903102 10806180
65. Clinical relevance of airway remodelling in airway diseases. AL James, S Wenzel, Eur Respir J 2007 30 134 155 10.1183/09031936.00146905 17601971
66. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma. TL Hackett, Curr Opin Allergy Clin Immunol 2012 12 53 59 10.1097/ACI.0b013e32834ec6eb 22217512
67. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Chakir, J Shannon, S Molet, M Fukakusa, J Elias, M Laviolette, LP Boulet, Q Hamid, J Allergy Clin Immunol 2003 111 1293 1298 10.1067/mai.2003.1557 12789232
68. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. AE Redington, J Madden, AJ Frew, R Djukanovic, WR Roche, ST Holgate, PH Howarth, Am J Respir Crit Care Med 1997 156 642 647 10.1164/ajrccm.156.2.9605065 9279252
69. Biology of the eosinophil. C Blanchard, ME Rothenberg, Adv Immunol 2009 101 81 121 19231593
70. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. EM Minshall, DY Leung, RJ Martin, YL Song, L Cameron, P Ernst, Q Hamid, Am J Respir Cell Mol Biol 1997 17 326 333 10.1165/ajrcmb.17.3.2733 9308919
71. Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma. SI Ochkur, EA Jacobsen, CA Protheroe, TL Biechele, RS Pero, MP McGarry, H Wang, KR O'Neill, DC Colbert, TV Colby, H Shen, MR Blackburn, CC Irvin, JJ Lee, NA Lee, J Immunol 2007 178 7879 7889 10.4049/jimmunol.178.12.7879 17548626
72. Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice. H Tanaka, M Komai, K Nagao, M Ishizaki, D Kajiwara, K Takatsu, G Delespesse, H Nagai, Am J Respir Cell Mol Biol 2004 31 62 68 10.1165/rcmb.2003-0305OC 14975941
73. Chronic OVA allergen challenged TNF p55/p75 receptor deficient mice have reduced airway remodeling. JY Cho, A Pham, P Rosenthal, M Miller, T Doherty, DH Broide, Int Immunopharmacol 2011 11 1038 1044 10.1016/j.intimp.2011.02.024 21382533
74. Eosinophils promote epithelial to mesenchymal transition of bronchial epithelial cells. A Yasukawa, K Hosoki, M Toda, Y Miyake, Y Matsushima, T Matsumoto, D Boveda-Ruiz, P Gil-Bernabe, M Nagao, M Sugimoto, Y Hiraguchi, R Tokuda, M Naito, T Takagi, CN D'Alessandro-Gabazza, S Suga, T Kobayashi, T Fujisawa, O Taguchi, EC Gabazza, PLoS One 2013 8 64281 10.1371/journal.pone.0064281 23700468
75. Mepolizumab and exacerbations of refractory eosinophilic asthma. P Haldar, CE Brightling, B Hargadon, S Gupta, W Monteiro, A Sousa, RP Marshall, P Bradding, RH Green, AJ Wardlaw, ID Pavord, N Engl J Med 2009 360 973 984 10.1056/NEJMoa0808991 19264686
76. Eosinophils are dispensable for allergic remodeling and immunity in a model of house dust mite-induced airway disease. R Fattouh, A Al-Garawi, M Fattouh, K Arias, TD Walker, S Goncharova, AJ Coyle, AA Humbles, M Jordana, Am J Respir Crit Care Med 2011 183 179 188 10.1164/rccm.200905-0736OC 20732990
77. Effect of bronchoconstriction on airway remodeling in asthma. CL Grainge, LC Lau, JA Ward, V Dulay, G Lahiff, S Wilson, S Holgate, DE Davies, PH Howarth, N Engl J Med 2011 364 2006 2015 10.1056/NEJMoa1014350 21612469
78. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. P Loke, MG Nair, J Parkinson, D Guiliano, M Blaxter, JE Allen, BMC Immunol 2002 3 7 10.1186/1471-2172-3-7 12098359
79. Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. P Loke, I Gallagher, MG Nair, X Zang, F Brombacher, M Mohrs, JP Allison, JE Allen, J Immunol 2007 179 3926 3936 10.4049/jimmunol.179.6.3926 17785830
80. Alternative activation of macrophages: an immunologic functional perspective. FO Martinez, L Helming, S Gordon, Annu Rev Immunol 2009 27 451 483 10.1146/annurev.immunol.021908.132532 19105661
81. Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages. A Gratchev, J Kzhyshkowska, J Utikal, S Goerdt, Scand J Immunol 2005 61 10 17 10.1111/j.0300-9475.2005.01524.x 15644118
82. Exploring the full spectrum of macrophage activation. DM Mosser, JP Edwards, Nat Rev Immunol 2008 8 958 969 10.1038/nri2448 19029990
83. Neutrophil-derived elastase induces TGF-beta1 secretion in human airway smooth muscle via NF-kappaB pathway. KY Lee, SC Ho, HC Lin, SM Lin, CY Liu, CD Huang, CH Wang, KF Chung, HP Kuo, Am J Respir Cell Mol Biol 2006 35 407 414 10.1165/rcmb.2006-0012OC 16690986
84. Neutrophil elastase converts human immature dendritic cells into transforming growth factor-beta1-secreting cells and reduces allostimulatory ability. PC Maffia, SE Zittermann, ML Scimone, N Tateosian, N Amiano, D Guerrieri, V Lutzky, D Rosso, HE Romeo, VE Garcia, AC Issekutz, HE Chuluyan, Am J Pathol 2007 171 928 937 10.2353/ajpath.2007.061043 17690184
85. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. M Hoshino, Y Nakamura, J Sim, J Shimojo, S Isogai, J Allergy Clin Immunol 1998 102 783 788 10.1016/S0091-6749(98)70018-1 9819295
86. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Lötvall, CA Akdis, LB Bacharier, L Bjermer, TB Casale, A Custovic, RF Lemanske, AJ Wardlaw, SE Wenzel, PA Greenberger, J Allergy Clin Immunol 2011 127 355 360 10.1016/j.jaci.2010.11.037 21281866
87. Severe asthma: from characteristics to phenotypes to endotypes. S Wenzel, Clin Exp Allergy 2012 42 650 658 10.1111/j.1365-2222.2011.03929.x 22251060
88. Transforming growth factor-β impairs glucocorticoid activity in the A549 lung adenocarcinoma cell line. S Salem, T Harris, JS Mok, MY Li, CR Keenan, MJ Schuliga, AG Stewart, Br J Pharmacol 2012 166 2036 2048 10.1111/j.1476-5381.2012.01885.x 22300324
89. T-helper type 2-driven inflammation defines major subphenotypes of asthma. PG Woodruff, B Modrek, DF Choy, G Jia, AR Abbas, A Ellwanger, LL Koth, JR Arron, JV Fahy, Am J Respir Crit Care Med 2009 180 388 395 10.1164/rccm.200903-0392OC 19483109
90. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. S Saglani, DN Payne, J Zhu, Z Wang, AG Nicholson, A Bush, PK Jeffery, Am J Respir Crit Care Med 2007 176 858 864 10.1164/rccm.200702-212OC 17702968
91. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. C Miranda, A Busacker, S Balzar, J Trudeau, SE Wenzel, J Allergy Clin Immunol 2004 113 101 108 10.1016/j.jaci.2003.10.041 14713914
92. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. OG McDonald, H Wu, W Timp, A Doi, AP Feinberg, Nat Struct Mol Biol 2011 18 867 874 10.1038/nsmb.2084 21725293
93. Modeling of epigenome dynamics identifies transcription factors that mediate Polycomb targeting. P Arnold, A Schöler, M Pachkov, PJ Balwierz, H Jørgensen, MB Stadler, E van Nimwegen, D Schübeler, Genome Res 2013 23 60 73 10.1101/gr.142661.112 22964890
94. Chromatin organization marks exon-intron structure. S Schwartz, E Meshorer, G Ast, Nat Struct Mol Biol 2009 16 990 995 10.1038/nsmb.1659 19684600
95. Differential chromatin marking of introns and expressed exons by H3K36me3. P Kolasinska-Zwierz, T Down, I Latorre, T Liu, XS Liu, J Ahringer, Nat Genet 2009 41 376 381 10.1038/ng.322 19182803
96. Persistent activation of dendritic cells after resolution of allergic airway inflammation breaks tolerance to inhaled allergens in mice. LS van Rijt, N Vos, M Willart, F Muskens, PP Tak, C van der Horst, HC Hoogsteden, BN Lambrecht, Am J Respir Crit Care Med 2011 184 303 311 10.1164/rccm.201101-0019OC 21562124
97. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. PA Wark, SL Johnston, F Bucchieri, R Powell, S Puddicombe, V Laza-Stanca, ST Holgate, DE Davies, J Exp Med 2005 201 937 947 10.1084/jem.20041901 15781584
98. Role of deficient type III interferon-lambda production in asthma exacerbations. M Contoli, SD Message, V Laza-Stanca, MR Edwards, PA Wark, NW Bartlett, T Kebadze, P Mallia, LA Stanciu, HL Parker, L Slater, A Lewis-Antes, OM Kon, ST Holgate, DE Davies, SV Kotenko, A Papi, SL Johnston, Nat Med 2006 12 1023 1026 10.1038/nm1462 16906156
99. HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. A López-Soto, AR Folgueras, E Seto, S Gonzalez, Oncogene 2009 28 2370 2382 10.1038/onc.2009.117 19430493
100. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. V Groh, J Wu, C Yee, T Spies, Nature 2002 419 734 738 10.1038/nature01112 12384702
101. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. DE Oppenheim, SJ Roberts, SL Clarke, R Filler, JM Lewis, RE Tigelaar, M Girardi, AC Hayday, Nat Immunol 2005 6 928 937 10.1038/ni1239 16116470
102. The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function. M Della Chiesa, S Carlomagno, G Frumento, M Balsamo, C Cantoni, R Conte, L Moretta, A Moretta, M Vitale, Blood 2006 108 4118 4125 10.1182/blood-2006-03-006700 16902152
103. EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction. I Akalay, B Janji, M Hasmim, MZ Noman, JP Thiery, F Mami-Chouaib, S Chouaib, Autophagy 2013 9 1104 1106 10.4161/auto.24728 23635487
104. A functional and regulatory map of asthma. N Novershtern, Z Itzhaki, O Manor, N Friedman, N Kaminski, Am J Respir Cell Mol Biol 2008 38 324 336 10.1165/rcmb.2007-0151OC 17921359
105. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. N Fens, AH Zwinderman, MP van der Schee, SB de Nijs, E Dijkers, AC Roldaan, D Cheung, EH Bel, PJ Sterk, Am J Respir Crit Care Med 2009 180 1076 1082 10.1164/rccm.200906-0939OC 19713445
106. Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. AR Brasier, S Victor, G Boetticher, H Ju, C Lee, ER Bleecker, M Castro, WW Busse, WJ Calhoun, J Allergy Clin Immunol 2008 121 30 37 e36 10.1016/j.jaci.2007.10.015 18206505
107. Allergic asthma biomarkers using systems approaches. G Sircar, B Saha, SG Bhattacharya, S Saha, Front Genetx 2014 4 308
108. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. IM Shapiro, AW Cheng, NC Flytzanis, M Balsamo, JS Condeelis, MH Oktay, CB Burge, FB Gertler, PLoS Genet 2011 7 1002218 10.1371/journal.pgen.1002218 21876675
109. The role of the miR-200 family in epithelial-mesenchymal transition. PS Mongroo, AK Rustgi, Cancer Biol Ther 2010 10 219 222 10.4161/cbt.10.3.12548 20592490
110. A systems view of epithelial-mesenchymal transition signaling states. S Thomson, F Petti, I Sujka-Kwok, P Mercado, J Bean, M Monaghan, SL Seymour, GM Argast, DM Epstein, JD Haley, Clin Exp Metastasis 2011 28 137 155 10.1007/s10585-010-9367-3 21194007
111. Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug. J Yang, JA Eddy, Y Pan, A Hategan, I Tabus, Y Wang, D Cogdell, ND Price, RE Pollock, AJ Lazar, KK Hunt, JC Trent, W Zhang, Mol Cell Proteomics 2010 9 2405 2413 10.1074/mcp.M110.000240 20651304
112. Integration of proteomics into systems biology of cancer. S Hanash, M Schliekelman, Q Zhang, A Taguchi, Wiley Interdiscip Rev Syst Biol Med 2012 4 327 337 10.1002/wsbm.1169 22407608
113. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. ND Heintzman, RK Stuart, G Hon, Y Fu, CW Ching, RD Hawkins, LO Barrera, S Van Calcar, C Qu, KA Ching, W Wang, Z Weng, RD Green, GE Crawford, B Ren, Nat Genet 2007 39 311 318 10.1038/ng1966 17277777
114. A protein interaction network associated with asthma. S Hwang, SW Son, SC Kim, YJ Kim, H Jeong, D Lee, J Theor Biol 2008 252 722 731 10.1016/j.jtbi.2008.02.011 18395227
115. A multiscale, spatially distributed model of asthmatic airway hyper-responsiveness. AZ Politi, GM Donovan, MH Tawhai, MJ Sanderson, AM Lauzon, JH Bates, J Sneyd, J Theor Biol 2010 266 614 624 10.1016/j.jtbi.2010.07.032 20678506
116. Multiscale image-based modeling and simulation of gas flow and particle transport in the human lungs. CL Lin, MH Tawhai, EA Hoffman, Wiley Interdiscip Rev Syst Biol Med 2013 5 643 655 10.1002/wsbm.1234 23843310
117. Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease. JL Richens, RA Urbanowicz, EA Lunt, R Metcalf, J Corne, L Fairclough, P O'Shea, Respir Res 2009 10 29 10.1186/1465-9921-10-29 19386108